Biotech Values

[mcbio]

CLVS -$10.50 p/m-48%..Leerick says should be bought if well below 15.. what does well below mean? Under 10?

I think their selective EGFR inhibitor sounds kind of interesting. I listened to a recent CC (not today's yet) and it will have potential PoC data in 2H13. I'm not sure I have a lot of confidence in their PARP inhibitor that PFE abandoned, and which CLVS in-licensed, even after they had clinical data.